Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses.
Saved in:
| Title: | Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses. |
|---|---|
| Authors: | Hansen, Christian Rønn1,2,3 Christian.Roenn@rsyd.dk, Bertelsen, Anders S.1, Hazell, Irene1, Stougaard, Sarah W.1,3, Johansen, Jørgen3,4, Overgaard, Jens5, Eriksen, Jesper Grau5,6, Zukauskaite, Ruta1,3 |
| Source: | Acta Oncologica. 2025 Special Issue, Vol. 64, p1205-1211. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0284186X |
|---|---|
| DOI: | 10.2340/1651-226X.2025.44049 |
